A Comparative Study of the Effect of Zilomol and Timolol Drop Following Intravitreal Injection of Bevacizumab on the Improvement of Diabetic Macular Edema

Zahedan University of Medical Sciences0 个研究点目标入组 34 人开始时间: 待定最近更新: 2024年1月22日

适应症

试验速览

暂无简介。

•People with bilateral diabetic macular edema (central retinal thickness more than 300 microns) with center-involved and thickness difference less than 25% between 2 eyes who have not undergone any eye interventions (such as eye surgery, intraocular injection) eye, eye lasers and eye treatment and eye local treatment) are not included.

•Patients during pregnancy and breastfeeding
•Active intraocular inflammation treated with topical corticosteroids
•Eye pathologies such as pterygium or corneal opacities that can affect the evaluation of study variables
•A patient with high eye pressure who is treated with intraocular pressure lowering drugs and corticosteroids
•History of allergy to CAIs and sulfonamide drugs
•Patients who use systemic antihypertensive drugs such as acetazolamide or beta blockers

发起方

Zahedan University of Medical Sciences